DELTA HEPATITIS AND HEPATITIS C IN HEMOPHILIA

血友病中的三角洲肝炎和丙型肝炎

• 批准号: 6304739
• 负责人: JOAN GILL
• 金额: $ 0.07万
• 依托单位: MEDICAL COLLEGE OF WISCONSIN
• 依托单位国家: 美国
• 财政年份: 1999
• 资助国家: 美国
• 起止时间: 1999-12-01 至 2000-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6304739
• 关键词: biomarker; cancer risk; chronic disease /disorder; clinical research; cofactor; disease /disorder proneness /risk; epidemiology; helper T lymphocyte; hemophilia As; hepatitis B; hepatitis B virus group; hepatitis C; hepatitis C virus; hepatitis D; hepatitis D virus; hepatocellular carcinoma; human subject; interleukin 10; interleukin 2; liver failure; medical complication; virus RNA; virus load

This proposal attempts to determine the prevalence of hepatitis B, C and delta virus markers in patients with hemophilia and to define the cofactors that place a hepatitis patient at risk for developing chronic hepatitis, liver failure and hepatocellular carcinoma.

该提案试图确定血友病患者中B、C和δ病毒标志物的患病率，并确定使肝炎患者处于发展慢性肝炎、肝衰竭和肝细胞癌风险的辅助因子。